Plasma EBV DNA concentration and clearance rate as good prognostic factors for metastatic nasopharyngeal carcinoma

被引：0
|
作者：
Hsu, Cheng-Lung [1 ]
Huang, Shiang-Fu [1 ]
Chang, Kai-Ping [1 ]
Wang, Hung-Ming [1 ]
机构：
[1] Chang Gung Mem Hosp, Taipei 10591, Taiwan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-729
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
729
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
    Wang, Wen-Yi
    Twu, Chih-Wen
    Chen, Hsin-Hong
    Jan, Jian-Sheng
    Jiang, Rong-San
    Chao, Jeffrey Y. C.
    Liang, Kai-Li
    Chen, Kuan-Wen
    Wu, Ching-Te
    Lin, Jin-Ching
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (03) : 1016 - 1024
  • [2] Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma
    Hsu, Cheng-Lung
    Chang, Kai-Ping
    Lin, Chien-Yu
    Chang, Hsien-Kun
    Wang, Cheng-Hsu
    Lin, Tung-Liang
    Liao, Chun-Ta
    Tsang, Ngan-Ming
    Lee, Li-Yu
    Chan, Sheng-Chieh
    Ng, Shu-Hang
    Li, Hsin-Pai
    Chang, Yu-Sun
    Wang, Hung-Ming
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (08): : 1064 - 1070
  • [3] Plasma EBV DNA and cell-free GAPDH DNA as prognostic factors of locally advanced nasopharyngeal carcinoma
    Chen, J.
    Ting, L.
    Ko, J.
    Lou, P.
    Wang, C.
    Yang, T.
    Hong, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Prognostic factors in metastatic nasopharyngeal carcinoma
    Khanfira, A.
    Frikha, M.
    Ghorbel, A.
    Drira, M. M.
    Daoud, J.
    [J]. CANCER RADIOTHERAPIE, 2007, 11 (08): : 461 - 464
  • [5] Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma
    Twu, Chih-Wen
    Wang, Wen-Yi
    Liang, Wen-Miin
    Jan, Jian-Sheng
    Jiang, Rong-San
    Chao, Jeffrey
    Jin, Ying-Tai
    Lin, Jin-Ching
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 130 - 137
  • [6] Long-term prognostic impacts of pretreatment plasma EBV DNA status in nasopharyngeal carcinoma
    Lin, J. C.
    Wang, W. Y.
    Huang, J. W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S319 - S320
  • [7] Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma
    Peng, Hao
    Chen, Bin-bin
    Wang, Xiao-hui
    Mo, Yun-Xian
    Han, Fei
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] PLASMA EBV DNA CONCENTRATION CORRELATES WITH FDG PET IN NASOPHARYNGEAL CARCINOMA TREATED WITH INDUCTION CHEMOTHERAPY
    Rahal, M.
    Abdullah, H.
    Halawani, H.
    Zagloul, H.
    Al Buali, A.
    Alfaraj, A. A.
    Abdulkhalek, H.
    Hassan, E. A.
    Ahluwalia, A.
    Medhat, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 337 - 338
  • [9] Shorter Half-Life Clearance of Plasma EBV DNA Is a Significant Prognostic Factor of Non-Metastatic Nasopharyngeal Carcinoma Treated with Radical Intensity-Modulated Radiation Therapy
    Chan, S. K.
    Chan, S. Y.
    Choi, H. C. W.
    Tong, C. C.
    Lam, K. O.
    Kwong, D. L.
    Leung, T. W.
    Luk, M. Y.
    Lee, A. W. M.
    Lee, V. H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E392 - E392
  • [10] Correlation between plasma EBV DNA and clinical response to pembrolizumab in patients with advanced or metastatic nasopharyngeal carcinoma
    Kao, H. -F.
    Hsu, C.
    Huang, H. -C.
    Cheng, J.
    Hong, R. -L.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 6 - 7
12345